These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1090 related articles for article (PubMed ID: 34681922)

  • 1. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential.
    Zhang X; Agborbesong E; Li X
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction and the AKI-to-CKD transition.
    Jiang M; Bai M; Lei J; Xie Y; Xu S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1105-F1116. PubMed ID: 33073587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological Role of Organelle Stress/Crosstalk in AKI-to-CKD Transition.
    Maekawa H; Inagi R
    Semin Nephrol; 2019 Nov; 39(6):581-588. PubMed ID: 31836040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic Approaches to Improve Mitochondrial Function in AKI and CKD.
    Szeto HH
    J Am Soc Nephrol; 2017 Oct; 28(10):2856-2865. PubMed ID: 28778860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial Signaling, the Mechanisms of AKI-to-CKD Transition and Potential Treatment Targets.
    Chang LY; Chao YL; Chiu CC; Chen PL; Lin HY
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage.
    Franzin R; Stasi A; Fiorentino M; Stallone G; Cantaluppi V; Gesualdo L; Castellano G
    Front Immunol; 2020; 11():734. PubMed ID: 32457738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic impairment of mitochondrial bioenergetics and β-oxidation promotes experimental AKI-to-CKD transition induced by folic acid.
    Aparicio-Trejo OE; Avila-Rojas SH; Tapia E; Rojas-Morales P; León-Contreras JC; Martínez-Klimova E; Hernández-Pando R; Sánchez-Lozada LG; Pedraza-Chaverri J
    Free Radic Biol Med; 2020 Jul; 154():18-32. PubMed ID: 32360615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney disease.
    Mapuskar KA; Wen H; Holanda DG; Rastogi P; Steinbach E; Han R; Coleman MC; Attanasio M; Riley DP; Spitz DR; Allen BG; Zepeda-Orozco D
    Redox Biol; 2019 Jan; 20():98-106. PubMed ID: 30296702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyl-cysteine increases cellular dysfunction in progressive chronic kidney damage after acute kidney injury by dampening endogenous antioxidant responses.
    Small DM; Sanchez WY; Roy SF; Morais C; Brooks HL; Coombes JS; Johnson DW; Gobe GC
    Am J Physiol Renal Physiol; 2018 May; 314(5):F956-F968. PubMed ID: 29357409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases.
    Aranda-Rivera AK; Cruz-Gregorio A; Aparicio-Trejo OE; Pedraza-Chaverri J
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasmall Polyphenol-NAD
    Kong Y; Chen X; Liu F; Tang J; Zhang Y; Zhang X; Zhang L; Zhang T; Wang Y; Su M; Zhang Q; Chen H; Zhou D; Yi F; Liu H; Fu Y
    Adv Mater; 2024 Jul; 36(30):e2310731. PubMed ID: 38805174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of NAD+ boosting on kidney ischemia-reperfusion injury.
    Morevati M; Egstrand S; Nordholm A; Mace ML; Andersen CB; Salmani R; Olgaard K; Lewin E
    PLoS One; 2021; 16(6):e0252554. PubMed ID: 34061900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Kidney Injury to Chronic Kidney Disease Transition.
    Fiorentino M; Grandaliano G; Gesualdo L; Castellano G
    Contrib Nephrol; 2018; 193():45-54. PubMed ID: 29393158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
    Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
    Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
    Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of mitochondria in reno-cardiac diseases: A study of bioenergetics, biogenesis, and GSH signaling in disease transition.
    Lumpuy-Castillo J; Amador-Martínez I; Díaz-Rojas M; Lorenzo O; Pedraza-Chaverri J; Sánchez-Lozada LG; Aparicio-Trejo OE
    Redox Biol; 2024 Oct; 76():103340. PubMed ID: 39250857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of renin-angiotensin system in acute kidney injury-chronic kidney disease transition.
    Chou YH; Chu TS; Lin SL
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():121-125. PubMed ID: 30298669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition.
    Lu M; Wang P; Qiao Y; Jiang C; Ge Y; Flickinger B; Malhotra DK; Dworkin LD; Liu Z; Gong R
    Redox Biol; 2019 Sep; 26():101275. PubMed ID: 31349118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in acute kidney injury and its consequences and impact on chronic kidney disease.
    Zuk A; Bonventre JV
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):397-405. PubMed ID: 30925515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria as therapeutic targets in acute kidney injury.
    Hall AM; Schuh CD
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):355-62. PubMed ID: 27166518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.